Top compounds associated with response to AHRR


Feature Type Standardized
Nominal ANOVA
mRNA dabrafenib CTRPv2 pan-cancer AAC 0.17 0.0006
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.12 0.0006
mRNA GDC-0879 CTRPv2 pan-cancer AAC 0.12 0.0009
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0009
mRNA LAQ824 GDSC1000 pan-cancer AAC -0.11 0.001
mRNA AZ628 GDSC1000 pan-cancer AAC 0.16 0.001
mRNA Erlotinib CCLE pan-cancer AAC -0.16 0.001
mRNA 17-AAG GDSC1000 pan-cancer AAC 0.1 0.001
mRNA Rapamycin GDSC1000 pan-cancer AAC -0.16 0.002
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.002
Download CSV